Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Agnosia 4Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pain, Postoperative 2Neoplasms 2Uveal Melanoma 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain 1Opioid-Related Disorders 1Mucositis 1Mouth Neoplasms 1Melanoma 1Intra-abdominal Cancer 1Ileus 1Goiter 1Eye Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Cancer Pain 1Brain Neoplasms 1

Interventions

Bupivacaine 2acetaminophen, codeine drug combination 1Triiodothyronine 1Tramadol 1Thyroxine 1Ropivacaine 1Remote Consultation 1Negative-Pressure Wound Therapy 1Ketorolac 1Indocyanine Green 1Hyaluronic Acid 1Glucose 1Epinephrine 1Dexmedetomidine 1Clinical Protocols 1Capsules 1Calcium Carbonate 1Calcitriol 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Goiter × Tramadol × Clear all
NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

DHR Health Institute for Research and Development

Phase 4 Completed
126 enrolled
Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡